InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Raben David. Director active across 1 company, notably Bicara Therapeutics Inc.. In total, 5 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €107k. Activity tracked since 9 October 2025. The latest transaction was disclosed on 27 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Raben David is a declarant linked to Bicara Therapeutics Inc., where he is Chief Medical Officer. Across the 4 filings recorded, the transactions observed in the sampled recent filings cover the period from 2025-10-10 to 2026-04-28, with €0 of buys and €107332 of sells, and the modal transaction nature is Levée d'options.